A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients With Extensive Small-Cell Lung Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2014.00271
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study

Clinical Genitourinary Cancer
OncologyUrology
2016English

Circulating Tumor Microemboli Diagnostics for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Serum CA19-9 as a Marker of Circulating Tumor Cells in First Reflux Blood of Colorectal Cancer Patients

Oncotarget
Oncology
2017English

Small Cell Lung Cancer: Recruitment of Macrophages by Circulating Tumor Cells

OncoImmunology
OncologyAllergyImmunology
2015English

Receptor Tyrosine Kinase Expression of Circulating Tumor Cells in Small Cell Lung Cancer

Oncoscience
Cancer ResearchOncology
2015English

Circulating Tumor Cells Enumerated by a Centrifugal Microfluidic Device as a Predictive Marker for Monitoring Ovarian Cancer Treatment: A Pilot Study

Diagnostics
Clinical Biochemistry
2020English

The Prognostic Role of Circulating CD8+ T Cell Proliferation in Patients With Untreated Extensive Stage Small Cell Lung Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy